MET and non-small cell lung carcinoma: However, in NSCLC there seems to be a MET gene dose effect (the higher MET-GCN/cell, the higher are chances of response to MET-TKIs), causing uncertainty regarding which levels of MET-receptor overexpression and MET-gene amplification are actionable targets in NSCLC [4,5,25].